1. Home
  2. Stock quotes
  3. Stock Provention Bio
Provention Bio logo

Provention Bio PRVB

Annual report 2022
added 03-29-2023

report update icon

Country

 usaUSA

IPO year

 2018

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 74.7 M

Market Cap[1]

 $ 2.37 B

EBITDA (LTM)

 $ -115 M

P/E (LTM)

 -

P/S (LTM)

 1175.58

EPS (LTM)

 -1.58

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
FSD Pharma FSD Pharma
HUGE
 		- 5743.5 % $ 69.7 M Nasdaq Capital Market canadaCanada
MorphoSys AG MorphoSys AG
MOR
 		- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
 		- -10.17 % $ 12.2 K NYSE American usaUSA
I-Mab I-Mab
IMAB
 		- - $ 866 M Nasdaq Global Select Market chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
 		- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		- - $ 40.3 B Nasdaq Global Select Market usaUSA
Biophytis SA Biophytis SA
BPTS
 		- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Genfit SA Genfit SA
GNFT
 		- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
 		$ 0.83 -0.36 % $ 37.9 M Nasdaq Capital Market israelIsrael
Athira Pharma Athira Pharma
ATHA
 		- - $ 269 M Nasdaq Global Select Market usaUSA
Exelixis Exelixis
EXEL
 		$ 46.61 -4.29 % $ 12.7 B Nasdaq Global Select Market,SPB usaUSA
Fortress Biotech Fortress Biotech
FBIO
 		$ 2.48 -2.78 % $ 69.2 M Nasdaq Capital Market usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
 		$ 8.41 - $ 6.83 B Nasdaq Global Select Market spainSpain
Heron Therapeutics Heron Therapeutics
HRTX
 		$ 1.25 -4.96 % $ 208 M Nasdaq Global Select Market,SPB usaUSA
InflaRx N.V. InflaRx N.V.
IFRX
 		$ 2.55 1.8 % $ 172 M Nasdaq Global Select Market germanyGermany
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
 		$ 75.46 -1.82 % $ 12.1 B Nasdaq Global Select Market,SPB usaUSA
BioNTech SE BioNTech SE
BNTX
 		$ 94.11 -1.21 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		- - - MOEX russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		- - $ 231 M Nasdaq Global Market usaUSA
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
 		$ 214.55 -7.74 % $ 3.92 B Nasdaq Global Select Market,SPB usaUSA
Liquidia Corporation Liquidia Corporation
LQDA
 		$ 42.63 1.16 % $ 3.67 B Nasdaq Capital Market usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
 		$ 21.97 2.28 % $ 3.64 B Nasdaq Global Select Market,SPB usaUSA
Mirum Pharmaceuticals Mirum Pharmaceuticals
MIRM
 		$ 100.2 -8.98 % $ 5.03 B Nasdaq Global Select Market usaUSA
Advaxis Advaxis
ADXS
 		- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
 		$ 3.14 -0.48 % $ 653 M Nasdaq Global Market,SPB usaUSA
Genmab A/S Genmab A/S
GMAB
 		$ 27.64 -0.9 % $ 17.1 B Nasdaq Global Select Market danmarkDanmark
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		$ 3.55 5.97 % $ 5.84 M NYSE American israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Genprex Genprex
GNPX
 		$ 0.89 -0.2 % $ 830 K Nasdaq Capital Market usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		- - $ 1.01 B Nasdaq Global Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		- - $ 867 M Nasdaq Global Market germanyGermany
Matinas BioPharma Holdings Matinas BioPharma Holdings
MTNB
 		$ 0.66 -3.02 % $ 3.61 M NYSE American usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		- - $ 26.5 M Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
 		- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Nanobiotix S.A. Nanobiotix S.A.
NBTX
 		$ 44.19 5.57 % $ 286 B Nasdaq Global Select Market franceFrance
Aptose Biosciences Aptose Biosciences
APTO
 		- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Aptinyx Aptinyx
APTX
 		- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Akouos Akouos
AKUS
 		- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Allakos Allakos
ALLK
 		- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
AlloVir AlloVir
ALVR
 		- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		$ 22.5 -6.93 % $ 2.86 B Nasdaq Global Select Market,SPB usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
 		- 3.16 % $ 1.9 M Nasdaq Global Select Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
 		- -11.43 % $ 502 K NYSE American usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
 		- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		- - $ 2.17 B Nasdaq Global Market usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
 		- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
Applied Therapeutics Applied Therapeutics
APLT
 		- - $ 8.42 M Nasdaq Global Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.